About Hope
News & Events
Services & Products
R&D
Production
Contact Us
——
Company News
Recent Events
[Exciting News] Haibu Pharma≥ ceutical's Ibrutinib Capsules have rβ∞©eceived the second domes≠∏γtic drug registration approval.
Recently, the ibruti☆←♠nib capsules (140mg) ₩÷±∞independently developed b∑®✘y Haibu Pharmaceutical≥ε have obtained the production appr∏σαoval, making it the second company in→↔™¶ China to receive appπα™★roval for this product ☆↕→'after Xiansheng Pharmaceutical.
16
2024-12
[Haibu Pharmaceutical] Pregabalin oral € >solution has successfully been selected₩" in the tenth batch of"©γ national centralized proc÷≈urement!
The oral solution of Ruianxi® Pregaba♥♥≈→lin has successfully ≥πbeen selected in the tenth bat≤λ↑ch of national procurement♠>φα! This is not only a highπ recognition of Haibu Pharmaceuti∏✘γcal's compliance qualific∑λ™&ations and product qualityγ±, but also a great blessing for many ✔patients.
07
2024-11
Glorious Moment丨Haibu Pharmace₩×¥utical has received multiple✔∑★¶ honors!
Beijing Haibu Pharmaceutical Technol≈ πogy Co., Ltd. has been honored as β↓one of the "Top 50 R&am→ ←♣p;D Companies in the Pharmaceuticaσ &l Industry for 2023-20™≠24", marking another£★ consecutive year for Haibu Pharmaceut©•∑ical to receive this accolade.
05
【Announcement】Beijing Haibu Pharmac♣Ωeutical Technology Co., ΩΩ₽φLtd. Hazardous Waste Pα¶§©ollution Prevention and Control Inform↔Ω₹γation Announcement
According to the requi§π©rements of the "Law of th>™∏e People's Republic of China on tΩ₹πhe Prevention and Control 'of Environmental Pollution by≥ Solid Waste", units that gene& ✔rate solid waste shall t&"∞imely disclose information on solid "<δwaste pollution to the envλΩαironment in accordanceε with the law and actively acc£∏®↓ept social supervisioσ♣n.
30
2024-10
【Good News】Haibu Pharmaceutical<≥'s Riluzole raw material hσ&✘δas obtained the FDA regis♠÷↔tration number in the U"≈↓δnited States.
Our company has a wide variety of raw m&★₩≈aterials with stable supply. Welco©♥'πme to inquire. Mr. Wσ•∞ei: 18515385101; Mr. Wu: 15 ↓§"600038801
24
【Good News】Haibu Pharmaceut&✘≥<ical's Riluzole Tablets (40mg) §≤↔ have obtained clinical trial approval.
Introduction: The indicati§×>ons are to improve the fol≈®αlowing symptoms of uterine fibσσroids (excessive menstruation, lower a ©π↓bdominal pain, back pain">¶, anemia); to alleviate the ↓✘☆→pain of endometriosis.